---
title: "Spectrum: Epinephrine bulk API — FDA announcement Jan 9, 2023 | Is It on Recall"
description: "Product discoloration"
url: https://isitonrecall.com/recall/fdapress-ce3922212e3b0594-spectrum-epinephrine-bulk-api/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# Spectrum: Epinephrine bulk API — FDA announcement Jan 9, 2023

Reported terminated

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jan 9, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Epinephrine bulk API
- **Reason**: Product discoloration
- **Classification**: Not supplied
- **Recalling firm**: Spectrum Laboratory Products Inc.
- **Quantity**: Not supplied
- **Agency-reported status**: Terminated in FDA listing
- **Source record identifier**: ce3922212e3b0594

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/spectrum-laboratory-products-inc-issues-voluntary-worldwide-recall-epinephrine-l-adrenaline-usp-bulk)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Epinephrine (L-Adrenaline) USP bulk API Powder, is used in manufacturing and compounding of finished dose epinephrine prescription products which can be used to treat a variety of medical conditions including anaphylaxis and other severe immediate hypersensitivity reactions, asthma, bronchospasm, airway edema, nasal congestion, dilation during intraocular surgery, vasoconstrictor with local anesthetics, hypotension or shock, heart failure, bradycardia or atrioventricular block, and sudden cardiac arrest. The Epinephrine (L-Adrenaline) USP bulk API Powder is packaged in amber glass bottles enclosed in a vacuum sealed pouch. NDC’s, Package sizes, lot numbers and expiration dates can be found in the table below. The affected Epinephrine, USP product can be identified by Spectrum catalog number EP130. Product was distributed directly from Spectrum facilities nationwide in the USA and to Canada.; Product \| NDC \| Package Size \| Lot # \| Exp Date; Epinephrine, USP (Product code EP130); 49452-2740-2 \| 1 KG \| 1KG0865 \| 31-Mar-2023; 49452-2740-1 \| 100 GM \| 2KL0353 2KF0151 \| 30-Sep-2023 31-Mar-2023; 49452-2740-4 \| 1 GM; 49452-2740-3 \| 25 GM; 49452-2740-5 \| 5 GM |

Match all identifying details in the current notice. A brand name alone is not enough.

## Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

**FDA company announcement, table 1**

| Product | NDC | Package Size | Lot # | Exp Date |
| --- | --- | --- | --- | --- |
| Epinephrine, USP (Product code EP130) |  |  |  |  |
| Epinephrine, USP (Product code EP130) | 49452-2740-2 | 1 KG | 1KG0865 | 31-Mar-2023 |
| Epinephrine, USP (Product code EP130) | 49452-2740-1 | 100 GM | 2KL0353 2KF0151 | 30-Sep-2023 31-Mar-2023 |
| Epinephrine, USP (Product code EP130) | 49452-2740-4 | 1 GM | 2KL0353 2KF0151 | 30-Sep-2023 31-Mar-2023 |
| Epinephrine, USP (Product code EP130) | 49452-2740-3 | 25 GM | 2KL0353 2KF0151 | 30-Sep-2023 31-Mar-2023 |
| Epinephrine, USP (Product code EP130) | 49452-2740-5 | 5 GM | 2KL0353 2KF0151 | 30-Sep-2023 31-Mar-2023 |

Announcement retrieved Oct 1, 2026. [Official announcement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/spectrum-laboratory-products-inc-issues-voluntary-worldwide-recall-epinephrine-l-adrenaline-usp-bulk).

## Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Fda listing date**: Jan 9, 2023
- **Company announcement date**: Jan 9, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers with questions regarding this recall can contact Spectrum Laboratory Products, Inc. by 800-772-8786 or compliance@spectrumchemical.com on Monday to Friday from 8 am to 5 pm, pacific time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/spectrum-laboratory-products-inc-issues-voluntary-worldwide-recall-epinephrine-l-adrenaline-usp-bulk)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Spectrum Laboratory Products, Inc. records](https://isitonrecall.com/brand/spectrum-laboratory-products-inc/)